Correspondence 0001193125-24-272146 from Korro Bio, Inc. (KRRO) (CIK 0001703647) (KRRO)
Korro Bio, Inc. (KRRO) (CIK 0001703647)
Date: Dec. 6, 2024 · CIK: 0001703647 · Accession: 0001193125-24-272146
AI Filing Summary & Sentiment
File numbers found in text: 333-283552
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Attention: Mr. Daniel Crawford Requested Date: December 6, 2024 Requested Time: 4:05 p.m., Eastern Time
Re: Korro Bio, Inc.
Dear Mr. Crawford:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Korro Bio, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to December 6, 2024, at 4:05 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP, by calling Marianne Sarrazin at (415) 733-6134.
If you have any questions regarding this request, please contact Marianne Sarrazin of Goodwin Procter LLP at (415) 733-6134.
Sincerely,
KORRO BIO, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP VIA EDGAR December 6, 2024 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Mr. Daniel Crawford Re: Korro Bio, Inc. Acceleration Request for Registration Statement on Form S-3 File No. 333-283552 Acceleration Request Requested Date: December 6, 2024 Requested Time: 4:05 p.m., Eastern Time Dear Mr. Crawford: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Korro Bio, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to December 6, 2024, at 4:05 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP, by calling Marianne Sarrazin at (415) 733-6134. If you have any questions regarding this request, please contact Marianne Sarrazin of Goodwin Procter LLP at (415) 733-6134. Sincerely, KORRO BIO, INC. /s/ Vineet Agarwal Vineet Agarwal Chief Financial Officer Korro Bio, Inc. cc: Ram Aiyar, President, Chief Executive Officer and Director, Korro Bio, Inc. Jeffrey Cerio, General Counsel, Korro Bio, Inc. Kingsley L. Taft, Esq., Goodwin Procter LLP Marianne Sarrazin, Esq., Goodwin Procter LLP